Medical Communications

AbbVie is to receive $330 million after Reata Pharmaceuticals reacquired development, manufacturing and commercialisation rights to a portfolio of Nrf2 …

NICE has announced it has made an about-face on its earlier ruling for Clovis Oncology’s Rubraca (rucaparib), revealing that the …

Neurolign Technologies has acquired US-based eye diagnostic technology firm Neuro Kinetics for an undisclosed sum. Neuro Kinetics is based in …

Following our piece by AstraZeneca’s Patrick Connor introducing the Lung Ambition Alliance, a new cross-functional collaboration which aims to double …

Gilead Sciences have announced that Merdad Parsey will join the company as Chief Medical Officer, effective November 1st. Dr Parsey …

Lung cancer kills more patients than any other variety of cancer, accounting for around a fifth of all cancer-related deaths …

Johnson & Johnson have announced it has committed to ensuring more than $500 million is dedicated to R&D delivery programs …

Another week comes to an end at Pharmafile and we run down with the top 10 articles for the week. …

Arbutus Biopharma has announced its decision to terminate the development of its oral capsid inhibitor, known as AB-506, in the …

The UK’s Competition and Markets Authority (CMA) has provisionally found that three drug firms signed an illegal agreement which led …

AstraZeneca is celebrating as the FDA announced the approval of its IL-5 inhibitor Fasenra  (benralizumab) in a pre-filled, single-use auto-injector …

The US FDA has approved Gilead’s Descovy (emtricitabine/tenofovir alafenamide) as a second pre-exposure prophylaxis (PrEP) drug in at-risk adults and …

French pharma-giant Servier has purchased the medication Pixuvri, indicated for the treatment of non-Hodgkin B-cell lymphoma, from US-based CTI BioPharma. …

GlaxoSmithKline Chief Emma Walmsley has joined the chorus of more than a hundred of the UK’s most successful female business …

Biogen have announced updates to it senior leadership team with Alfred Sandrock being named Executive Vice President of Research and …